- Home
- Publications
- Publication Search
- Publication Details
Title
Role of miR-155 in drug resistance of breast cancer
Authors
Keywords
MicroRNA, miR-155, Drug resistance, Breast cancer
Journal
TUMOR BIOLOGY
Volume 36, Issue 3, Pages 1395-1401
Publisher
Springer Nature
Online
2015-03-06
DOI
10.1007/s13277-015-3263-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- On telomeres long and short
- (2015) Nathan Corbett et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- MiRNA-155 targets myosin light chain kinase and modulates actin cytoskeleton organization in endothelial cells
- (2014) Martina Weber et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
- (2014) Marek Sochor et al. BMC CANCER
- miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1
- (2014) R. Dinami et al. CANCER RESEARCH
- AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2+ breast tumor cells from Balb-neuT mice
- (2014) Nicole Grabinski et al. CELLULAR SIGNALLING
- The long reach of telomeres: Figure 1.
- (2014) Tom Misteli GENES & DEVELOPMENT
- MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
- (2014) Mao Ouyang et al. PLoS One
- Construction and Characterization of a Bacterial Artificial Chromosome Library for the Hexaploid Wheat Line 92R137
- (2014) Qingdong Zeng et al. Biomed Research International
- Effects of miR-155 Antisense Oligonucleotide on Breast Carcinoma Cell Line MDA-MB-157 and Implanted Tumors
- (2013) Shu-Rong Zheng et al. Asian Pacific Journal of Cancer Prevention
- P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer
- (2013) S.M. Donnelly et al. CURRENT MEDICINAL CHEMISTRY
- Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells
- (2013) D Raina et al. ONCOGENE
- MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer
- (2013) J Johansson et al. ONCOGENE
- Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells
- (2013) D. M. Gilkes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Oncogenic Role of miR-155 in Breast Cancer
- (2012) S. Mattiske et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Secrets of Drug Resistance in NSCLC Exposed by New Molecular Definition of EMT
- (2012) D. S. Neel et al. CLINICAL CANCER RESEARCH
- Role of miR-155 in breast cancer
- (2012) Jie Wang Frontiers in Bioscience-Landmark
- Mutant p53 drives invasion in breast tumors through up-regulation of miR-155
- (2012) P M Neilsen et al. ONCOGENE
- Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
- (2012) John M. Kyriakis et al. PHYSIOLOGICAL REVIEWS
- Regulation of MicroRNA-155 in Atherosclerotic Inflammatory Responses by Targeting MAP3K10
- (2012) Jianhua Zhu et al. PLoS One
- miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the E -miR-155 transgenic mouse model
- (2012) S. K. Sandhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model
- (2011) Jennifer Pasquier et al. Biology Direct
- miR-155 regulates HGAL expression and increases lymphoma cell motility
- (2011) L. N. Dagan et al. BLOOD
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mouse miRNA-709 directly regulates miRNA-15a/16-1 biogenesis at the posttranscriptional level in the nucleus: evidence for a microRNA hierarchy system
- (2011) Rui Tang et al. CELL RESEARCH
- The Complex Biology of FOXO
- (2011) Maria Monsalve et al. CURRENT DRUG TARGETS
- MicroRNA-mediated drug resistance in breast cancer
- (2011) Kristy R. Kutanzi et al. Clinical Epigenetics
- MicroRNA-155Regulates Cell Survival, Growth, and Chemosensitivity by TargetingFOXO3ain Breast Cancer
- (2010) William Kong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion
- (2009) Shuh Narumiya et al. CANCER AND METASTASIS REVIEWS
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines
- (2008) Nur Rahadiani et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of 24p3 as a Direct Target of Foxo3a Regulated by Interleukin-3 through the Phosphoinositide 3-Kinase/Akt Pathway
- (2008) Sungman Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-155 Is Regulated by the Transforming Growth Factor /Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA
- (2008) W. Kong et al. MOLECULAR AND CELLULAR BIOLOGY
- RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells
- (2008) S. Doublier et al. MOLECULAR CANCER RESEARCH
- Shhh! Silencing by microRNA-155
- (2008) G. Teng et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started